Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 7062.40% is 5098% above its 5-year average of 135.86%, near the high end of its 5-year range (67.20%–7062.40%).
1281.69% above its 12-month average of 511.14%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
7062.40%
RETURN ON EQUITY (ROE) AVG TTM
511.14%
RETURN ON EQUITY (ROE) AVG 3Y
226.96%
RETURN ON EQUITY (ROE) AVG 5Y
135.86%
RETURN ON EQUITY (ROE) AVG 10Y
75.32%
RETURN ON EQUITY (ROE) AVG 15Y
54.50%
RETURN ON EQUITY (ROE) AVG 20Y
46.40%
CURRENT VS TTM AVG
+1281.69%
CURRENT VS 3Y AVG
+3011.77%
CURRENT VS 5Y AVG
+5098.14%
CURRENT VS 10Y AVG
+9276.49%
CURRENT VS 15Y AVG
+12858.83%
CURRENT VS 20Y AVG
+15120.83%
SECTOR MEDIAN · HEALTHCARE
13.25%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
+53201.13%
vs the sector median at left
Mettler-Toledo International Inc.
Market Cap
$26.79B
Return on Equity (ROE)
7062.40%
TTM Avg
511.14%
3Y Avg
226.96%
5Y Avg
135.86%
Market Cap
$26.64B
Return on Equity (ROE)
11.65%
TTM Avg
9.71%
3Y Avg
9.35%
5Y Avg
12.84%
Market Cap
$25.99B
Return on Equity (ROE)
14.13%
TTM Avg
13.34%
3Y Avg
14.07%
5Y Avg
18.07%
Market Cap
$25.22B
Return on Equity (ROE)
25.41%
TTM Avg
12.92%
3Y Avg
11.29%
5Y Avg
9.83%
Market Cap
$24.78B
Return on Equity (ROE)
-9.62%
TTM Avg
-4.55%
3Y Avg
10.63%
5Y Avg
21.70%
Market Cap
$29.33B
Return on Equity (ROE)
5.97%
TTM Avg
9.02%
3Y Avg
4.86%
5Y Avg
4.86%
Market Cap
$23.79B
Return on Equity (ROE)
18.89%
TTM Avg
16.95%
3Y Avg
19.08%
5Y Avg
20.56%
Market Cap
$30.13B
Return on Equity (ROE)
1.09%
TTM Avg
29.98%
3Y Avg
64.02%
5Y Avg
111.55%
Market Cap
$30.16B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mettler-Toledo International Inc. (MTD) | $26.79B | 7062.40% | 511.14% | 226.96% | 135.86% |
| Labcorp Holdings Inc. (LH)vs › | $26.64B | 11.65% | 9.71% | 9.35% | 12.84% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.99B | 14.13% | 13.34% | 14.07% | 18.07% |
| Incyte Corporation (INCY)vs › | $25.22B | 25.41% | 12.92% | 11.29% | 9.83% |
| BioNTech SE (BNTX)vs › | $24.78B | -9.62% | -4.55% | 10.63% | 21.70% |
| Medline Inc. (MDLN)vs › | $29.33B | 5.97% | 9.02% | 4.86% | 4.86% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.79B | 18.89% | 16.95% | 19.08% | 20.56% |
| Waters Corporation (WAT)vs › | $30.13B | 1.09% | 29.98% | 64.02% | 111.55% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 14.51% | 21.84% | 21.53% | 32.27% |
| Zoetis Inc. (ZTS)vs › | $30.86B | 83.10% | 66.19% | 56.82% | 52.60% |
ROE
7062.4%
ROA
24.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2022-03-31 | 938.07% |
| 2021-12-31 | 448.59% |
| 2021-09-30 | 473.96% |
| 2021-06-30 | 372.20% |
| 2021-03-31 | 322.88% |
| 2020-12-31 | 213.23% |
| 2020-09-30 | 130.72% |
| 2020-06-30 | 121.49% |
| 2020-03-31 | 178.66% |
| 2019-12-31 | 133.35% |
| 2019-09-30 | 125.38% |
| 2019-06-30 | 108.47% |
| 2019-03-31 | 94.55% |
| 2018-12-31 | 86.87% |
| 2018-09-30 | 76.82% |
| 2018-06-30 | 72.63% |
| 2018-03-31 | 67.20% |
| 2017-12-31 | 68.70% |
| 2017-09-30 | 85.14% |
| 2017-06-30 | 93.77% |
| 2017-03-31 | 93.48% |
| 2016-12-31 | 88.37% |
| 2016-09-30 | 73.91% |
| 2016-06-30 | 72.66% |
| 2016-03-31 | 65.42% |
| 2015-12-31 | 60.78% |
| 2015-09-30 | 59.80% |
| 2015-06-30 | 53.00% |
| 2015-03-31 | 51.53% |
| 2014-12-31 | 47.00% |
| 2014-09-30 | 38.55% |
| 2014-06-30 | 34.87% |
| 2014-03-31 | 33.74% |
| 2013-12-31 | 32.74% |
| 2013-09-30 | 35.46% |
| 2013-06-30 | 36.79% |
| 2013-03-31 | 36.37% |
| 2012-12-31 | 35.16% |
| 2012-09-30 | 35.14% |
| 2012-06-30 | 35.68% |
| 2012-03-31 | 34.08% |
| 2011-12-31 | 34.50% |
| 2011-09-30 | 31.25% |
| 2011-06-30 | 29.81% |
| 2011-03-31 | 30.56% |
| 2010-12-31 | 30.09% |
| 2010-09-30 | 29.22% |
| 2010-06-30 | 27.91% |
| 2010-03-31 | 24.81% |
| 2009-12-31 | 24.27% |
| 2009-09-30 | 25.50% |
| 2009-06-30 | 29.98% |
| 2009-03-31 | 38.10% |
| 2008-12-31 | 40.29% |
| 2008-09-30 | 39.78% |
| 2008-06-30 | 35.39% |
| 2008-03-31 | 33.34% |
| 2007-12-31 | 30.71% |
| 2007-09-30 | 31.32% |
| 2007-06-30 | 29.11% |
| 2007-03-31 | 27.36% |
| 2006-12-31 | 24.97% |
| 2006-09-30 | 23.90% |
| 2006-06-30 | 20.31% |
| 2006-03-31 | 17.62% |
| 2005-12-31 | 16.53% |
| 2005-09-30 | 15.35% |
| 2005-06-30 | 15.26% |
| 2005-03-31 | 15.74% |
| 2004-12-31 | 14.98% |
| 2004-09-30 | 15.53% |
| 2004-06-30 | 15.16% |
| 2004-03-31 | 15.56% |
| 2003-12-31 | 14.65% |
| 2003-09-30 | 16.30% |
| 2003-06-30 | 16.80% |
